Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-induced host immunosuppression: Special focus on CLL
Christine E. Cutucache
International Immunopharmacology (2013) Vol. 17, Iss. 1, pp. 35-41
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
Marina Wierz, Sandrine Pierson, Léa Guyonnet, et al.
Blood (2018) Vol. 131, Iss. 14, pp. 1617-1621
Open Access | Times Cited: 125
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
Stefania Fiorcari, Rossana Maffei, Valentina Audrito, et al.
Oncotarget (2016) Vol. 7, Iss. 40, pp. 65968-65981
Open Access | Times Cited: 96
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic
Petra Langerbeins, Barbara Eichhorst
Acta Haematologica (2021) Vol. 144, Iss. 5, pp. 508-518
Open Access | Times Cited: 45
A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia
Tamar Tadmor, Manfred Welslau, Iwona Hus
Expert Review of Hematology (2017) Vol. 11, Iss. 1, pp. 57-70
Closed Access | Times Cited: 51
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia
Stefania Fiorcari, Rossana Maffei, Daniela Vallerini, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 43
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia
Stefania Fiorcari, Silvia Martinelli, Jenny Bulgarelli, et al.
Haematologica (2014) Vol. 100, Iss. 2, pp. 253-262
Open Access | Times Cited: 42
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections
Rossana Maffei, Monica Maccaferri, Laura Arletti, et al.
Blood Reviews (2019) Vol. 40, pp. 100635-100635
Closed Access | Times Cited: 35
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments
Stefania Fiorcari, Rossana Maffei, Claudio Giacinto Atene, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 217-217
Open Access | Times Cited: 27
The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide
Hila Shaim, Zeev Estrov, David Harris, et al.
Frontiers in Immunology (2018) Vol. 8
Open Access | Times Cited: 30
Cancer Therapy-associated Lymphoproliferative Disorders
Sergio Piña‐Oviedo, Roberto N. Miranda, L. Jeffrey Medeiros
The American Journal of Surgical Pathology (2017) Vol. 42, Iss. 1, pp. 116-129
Closed Access | Times Cited: 29
High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia
Marina Wierz, Bassam Janji, Guy Berchem, et al.
OncoImmunology (2018), pp. e1465167-e1465167
Open Access | Times Cited: 25
Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?
Ebru Aydin, Sebastian Faehling, Mariam Saleh, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 19
Design, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4+ T-lymphocytes
Brittany D. Conroy, Tyler A. Herek, Timothy D. Shew, et al.
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 22
Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells
Jaco A. C. van Bruggen, Gerritje J. W. van der Windt, Mels Hoogendoorn, et al.
Blood Advances (2022) Vol. 6, Iss. 14, pp. 4185-4195
Open Access | Times Cited: 12
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation
Claudio Giacinto Atene, Stefania Fiorcari, Nicolò Mesini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
Liam J O'Brien, Camille Guillerey, Kristen J. Radford
Cancers (2019) Vol. 11, Iss. 6, pp. 875-875
Open Access | Times Cited: 18
An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia
Morgan E. Wallace, Marice Alcantara, Yosuke Minoda, et al.
International Immunopharmacology (2015) Vol. 28, Iss. 2, pp. 897-900
Closed Access | Times Cited: 16
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia
Valentina Griggio, Giorgia Mandili, Candida Vitale, et al.
Oncotarget (2016) Vol. 8, Iss. 2, pp. 3274-3288
Open Access | Times Cited: 15
Current Approaches of Immune Checkpoint Therapy in Chronic Lymphocytic Leukemia
Saeid Taghiloo, Hossein Asgarian‐Omran
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 10, pp. 1408-1438
Closed Access | Times Cited: 5
Effects of the BTN162b2 mRNA COVID‐19 vaccine in humoral and cellular immunity in patients with chronic lymphocytic leukemia
Stefania Fiorcari, Claudio Giacinto Atene, Rossana Maffei, et al.
Hematological Oncology (2022) Vol. 41, Iss. 1, pp. 120-127
Open Access | Times Cited: 8
Lenalidomide in chronic lymphocytic leukemia: the present and future in the era of tyrosine kinase inhibitors
Rossana Maffei, Elisabetta Colaci, Stefania Fiorcari, et al.
Critical Reviews in Oncology/Hematology (2015) Vol. 97, pp. 291-302
Closed Access | Times Cited: 12
Cross‐talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review
Saeid Taghiloo, Hossein Asgarian‐Omran
European Journal Of Haematology (2024) Vol. 113, Iss. 1, pp. 4-15
Open Access | Times Cited: 1
IL-27 impact on NK cells activity: Implication for a robust anti-tumor response in chronic lymphocytic leukemia
Maral Hemati, Zahra Rasouli Nejad, Mohammad-Reza Shokri, et al.
International Immunopharmacology (2020) Vol. 82, pp. 106350-106350
Closed Access | Times Cited: 9
The top ten clues to understand the origin of chronic lymphocytic leukemia (CLL)
Ricardo García‐Muñoz, Jesús Feliu, Luis Llorente
Journal of Autoimmunity (2014) Vol. 56, pp. 81-86
Closed Access | Times Cited: 7
Conserved Molecular Underpinnings and Characterization of a Role for Caveolin-1 in the Tumor Microenvironment of Mature T-Cell Lymphomas
Tyler A. Herek, Timothy D. Shew, Heather N. Spurgin, et al.
PLoS ONE (2015) Vol. 10, Iss. 11, pp. e0142682-e0142682
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top